These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 657136)

  • 1. Isolation of a bone-resorptive factor from human cancer ascites fluid.
    Nimberg RB; Humphries DE; Lloyd WS; Badger AM; Cooperband SR; Wells H; Schmid K
    Cancer Res; 1978 Jul; 38(7):1983-9. PubMed ID: 657136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.
    Luben RA; Mundy GR; Trummel CL; Raisz LG
    J Clin Invest; 1974 May; 53(5):1473-80. PubMed ID: 4825237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and partial characterization of a Mr 52,000 glycoprotein from human cancer ascites fluid which stimulates bone resorption in vitro.
    Lamkin MS; Colclasure C; Lloyd WS; Doherty JM; Gonnerman W; Schmid K; Nimberg RB
    Cancer Res; 1986 Sep; 46(9):4650-5. PubMed ID: 3731118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of an inhibitor of type II interferon induction from tumor ascitic fluids.
    Matsubara S; Suzuki M; Nakamura M; Edo K; Ishida N
    Cancer Res; 1980 Jul; 40(7):2534-8. PubMed ID: 6248207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and partial characterization of a protein from cancer ascites fluid which stimulates the resorption of bone explants in vitro.
    Nimberg RB; Humphries DE; Lloyd WS; Wells H; Schmid K
    J Biol Chem; 1982 Mar; 257(5):2477-82. PubMed ID: 7061435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive activity of ascitic fluid from patients with cancer metastatic to the peritoneum.
    Badger AM; Cooperband SR; Merluzzi VJ; Glasgow AH
    Cancer Res; 1977 Apr; 37(4):1220-6. PubMed ID: 139204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
    Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Purification of skin reactive factor (SRF) in mice].
    Fahlbusch B; Gutsche W; Zschiesche W
    Allerg Immunol (Leipz); 1976; 22(1):93-6. PubMed ID: 135506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a bone resorptive factor from human cancer ascites fluid on rat bone cell calcium and cyclic AMP.
    Dziak R; Chang YW; Humphries D; Lloyd W; Wells H; Schmid K; Nimberg RB
    Calcif Tissue Int; 1980; 30(3):191-7. PubMed ID: 6249472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of an immunosuppressive peptide fraction from the serum of cancer patients.
    Nimberg RB; Glasgow AH; Menzoian JO; Constantian MB; Cooperband SR; Mannick JA; Schmid K
    Cancer Res; 1975 Jun; 35(6):1489-94. PubMed ID: 1131820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and enzymatic basis of bone resorption by human osteoclasts.
    Fuller K; Kirstein B; Chambers TJ
    Clin Sci (Lond); 2007 Jun; 112(11):567-75. PubMed ID: 17241109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical approach to the purification of human alpha1-fetoprotein from the ascites fluid of a hepatoma-bearing patient.
    Gold P; Labitan A; Wong HC; Freedman SO; Krupey J; Shuster J
    Cancer Res; 1978 Jan; 38(1):6-12. PubMed ID: 73414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resorption of bone by mouse peritoneal macrophages.
    Chambers TJ
    J Pathol; 1981 Dec; 135(4):295-9. PubMed ID: 6948941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production.
    Seckinger P; Klein-Nulend J; Alander C; Thompson RC; Dayer JM; Raisz LG
    J Immunol; 1990 Dec; 145(12):4181-4. PubMed ID: 2147937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a low molecular weight inhibitor of lymphocyte proliferation from tumorous ascites.
    Cornelius JG; Normann SJ
    J Immunol; 1988 Sep; 141(6):2175-80. PubMed ID: 3139755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition.
    Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE
    Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of alpha 1-acid glycoprotein molecular variants in ascitic fluid of cancer and non-cancer patients.
    Fujii M; Takahashi N; Hayashi H; Furusho T; Matsunaga K; Yoshikumi C
    Anticancer Res; 1988; 8(3):303-6. PubMed ID: 3389735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.
    Thomson BM; Mundy GR; Chambers TJ
    J Immunol; 1987 Feb; 138(3):775-9. PubMed ID: 3805716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients.
    Tamura K; Shibata Y; Matsuda Y; Ishida N
    Cancer Res; 1981 Aug; 41(8):3244-52. PubMed ID: 6166371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.